Namouni Fouad
SEC CIK 1815851 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Dir | 4,610 | — | — | 1 | 2021-06-30 | 2021-06-30 |
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Namouni Fouad made no open-market trades at APRE in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-30 | APRE | Aprea Therapeutics, Inc. | Namouni Fouad | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations